Access to diabetes care for children and young people: Pharma companies’ current actions and opportunities ahead Read more
Trump’s move to transform US pharma manufacturing raises doubts over its effectiveness: GlobalData Read more
OneSource Specialty Pharma’s Bangalore facility maintains US FDA compliance with VAI classification Read more